HMS Holdings Corp.
Oct. 28, 2011

HMS Holdings Corp. Announces Third Quarter 2011 Results; 2012 Guidance


NEW YORK--(BUSINESS WIRE)-- HMS Holdings Corp. (NASDAQ: HMSY) today announced its financial results for the third quarter of 2011.

For the quarter ended September 30, 2011, revenue increased 15.4% to $92.4 million, compared to $80.0 million for the same period a year ago. Net income for the quarter was $14.4 million or $0.17 per diluted common share compared to net income of $11.0 million or $0.13 per diluted common share for the same period a year ago, an increase of 30.7%.

For the nine months ended September 30, 2011, revenue increased 22.5% to $264.2 million, compared to $215.7 million for the same period a year ago. Net income for the nine months ended September 30, 2011 was $36.7 million or $0.42 per diluted common share, compared to net income of $27.7 million or $0.33 per diluted common share for the same period a year ago, an increase of 27.2%.

2011 Revised Guidance & 2012 Guidance

As a result of the delay in the issuance of the Medicaid RAC (Recovery Audit Contractor) final rule, states' progress in procuring, awarding and implementing RAC contracts was slower than anticipated and accordingly, the Company is revising revenue guidance for 2011 from $372.0 million to $363.0 million (+19.8% y/y). However, improved operational performance permits the Company to raise projected GAAP earnings per share (EPS) from $0.59 to $0.60 (+27.7% y/y) on a fully diluted basis.

The Company also announced initial guidance for 2012. Revenue is projected to grow to $435.0 million (+19.8% over revised 2011 guidance), fully diluted GAAP EPS is projected to increase to $0.74 (+23.3% over 2011 revised guidance).

"On the sales front, HMS continued to win competitive Medicaid RAC procurements in the third quarter," said Lucia. "We are very pleased that the components of CMS's Final Rule, which governs Medicaid RAC implementations and provides guidance to states, aligns favorably with HMS's capabilities, even though the delay in the rule slowed a number of state contract awards and implementations. With contract award activity resuming as states re-focus on Medicaid RAC, we're confident that the opportunity associated with this program will be realized in 2012 and beyond."

Q3 2011 Conference Call

HMS will be hosting its third quarter 2011 conference call and webcast with the investment community on Friday, October 28, 2011 at 9:00 am Eastern Time. Individuals can access the webcast at or listen to the call at 1-877-591-4959. International participants can listen to the call at 719-325-4791.

The webcast will be archived on the website. Individuals can listen to the replay at 1-888-203-1112. International participants can listen to the replay at 1-719-457-0820. The conference ID is 1811594. The replay will be available at 11 a.m. ET on October 28 through 11:59 p.m. ET on November 4, 2011.

The HMS Form 10-Q for the quarter September 30, 2011 will be filed and available on our website on or about November 9, 2011, and will contain additional information about our results of operations for the fiscal year-to-date. This press release and the interim financial statements herein will be available at for at least a 12-month period. Shareholders and interested investors are welcome to contact Investor Relations at 212-857-5986.

About HMS Holdings

HMS Holdings Corp. (NASDAQ: HMSY), is the nation's leader in coordination of benefits and program integrity services for healthcare payors. HMS's clients include health and human services programs in more than 40 states; commercial programs, including commercial plans, employers, and over 120 Medicaid managed care plans; the Centers for Medicare and Medicaid Services (CMS); and Veterans Administration facilities. As a result of the company's services, clients recovered over $1.8 billion in 2010, and saved billions of dollars more through prevention of erroneous payments.

Use of Non-GAAP Financials

This press release includes presentations of earnings before interest, taxes, depreciation and amortization (EBITDA) and adjusted EBITDA. Adjusted EBITDA represents EBITDA adjusted for stock-based compensation expense. EBITDA is a measure commonly used by the capital markets to value enterprises. EBITDA is a non-GAAP financial measure and is reconciled to income before income taxes, which the Company's management believes to be the most comparable generally accepted accounting principles ("GAAP") measure. Adjusted EBITDA results are calculated by adjusting GAAP income before income taxes to exclude the effects of depreciation, amortization of intangible assets, stock-based compensation expense, and net interest expense.

This press release also includes presentations of adjusted EPS. Adjusted EPS represents EPS adjusted for stock-based compensation expense and amortization of intangibles. Adjusted EPS is a non-GAAP financial measure and is reconciled to EPS, which the Company's management believes to be the most comparable GAAP measure.

The press release containing the reconciliation to GAAP measures is available on the Investor Section of our website.

The Company uses these non-GAAP financial measures for internal management purposes, when publicly providing guidance on possible future results, and as a means to evaluate period-to-period comparisons. The Company's management believes that these non-GAAP financial measures are a common measure used by investors and analysts to evaluate its performance. These non-GAAP financial measure are used in addition to and in conjunction with results presented in accordance with GAAP and reflect an additional way of viewing aspects of the Company's operations that, when viewed with GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provides a more complete understanding of the results of operations and trends affecting the Company's business. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, income before income taxes in accordance with GAAP.

Safe Harbor Statement

This Press Release contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such statements give our expectations or forecasts of future events; they do not relate strictly to historical or current facts. Forward-looking statements can be identified by words such as "anticipates," "estimates," "expects," "projects," "intends," "plans," "believes," "will," "target," "seeks," "forecast" and similar expressions. In particular, these include statements relating to future actions, business plans, objects and prospects, and future operating or financial performance. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated or projected. We caution you therefore against relying on any of these forward-looking statements.

Factors that could cause or contribute to such differences include, but are not limited to: the development by competitors of new or superior services or products or the entry into the market of new competitors; all the risks inherent in the development, introduction, and implementation of new products and services; the loss of a major customer, customer dissatisfaction or early termination of customer contracts triggering significant costs or liabilities; variations in our results of operations; negative results of government reviews, audits or investigations to verify our compliance with contracts and applicable laws and regulations; changing conditions in the healthcare industry which could simplify the reimbursement process and reduce the need for and price of our services; government regulatory, political and budgetary pressures that could affect the procurement practices and operations of healthcare organizations, reducing the demand for our services; our failure to comply with laws and regulations governing health data or to protect such data from theft and misuse. A further description of risks, uncertainties, and other matters can be found in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2010, a copy of which may be obtained from the Company's website at under the "Investor Relations" tab. Any forward-looking statements made by us in this Press Release speak only as of the date of this Press Release. Factors or events that could cause actual results to differ may emerge from time to time and it is not possible for us to predict all of them. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.

For the Three and Nine-Months Ended September 30, 2011 and 2010

(In thousands, except per share amounts)



Three months ended Sept 30,

Nine months ended Sept 30,

2011   2010 2011   2010
Revenue $ 92,356   $ 80,022   $ 264,159   $ 215,700  
Cost of services:
Compensation 31,762 27,211 94,604 76,391
Data processing 5,973 4,576 16,607 12,691
Occupancy 3,794 3,490 11,328 9,640
Direct project costs 9,893 9,818 30,546 25,596
Other operating costs 4,637 4,565 13,448 11,738
Amortization of acquisition related software
and intangibles   1,660     1,665     5,048     4,566  
Total cost of services 57,719 51,325 171,581 140,622
Selling, general & administrative expenses   10,560     10,419     31,932     28,899  
Total operating expenses   68,279     61,744     203,513     169,521  
Operating income 24,077 18,278 60,646 46,179
Interest expense (19 ) (24 ) (65 ) (70 )
Other income/(expense) 165 (31 ) 714 (31 )
Interest income   14     32     50     73  
Income before income taxes 24,237 18,255 61,345 46,151
Income taxes   9,822     7,209     24,691     18,414  
Net income $ 14,415   $ 11,046   $ 36,654   $ 27,737  
Basic income per common share data:
Net income per basic share $ 0.17   $ 0.13   $ 0.43   $ 0.34  
Weighted average common shares outstanding, basic   84,159     82,009     84,372     81,367  
Diluted income per share data:
Net income per diluted share $ 0.17   $ 0.13   $ 0.42   $ 0.33  
Weighted average common shares, diluted   86,869     85,450     87,233     85,040  

(In thousands, except share and per share amounts)


September 30,

December 31,


Current assets:
Cash and cash equivalents $ 140,451 $ 94,836
Accounts receivable, net of allowance of $650 at September 30, 2011

and $799 at December 31, 2010

83,483 75,123
Prepaid expenses and other current assets   12,563     10,089  
Total current assets 236,497 180,048
Property and equipment, net 46,561 44,713
Goodwill, net 107,026 107,414
Intangible assets, net 16,136 19,826
Other assets 847 904
Accounts receivable, long term   2,160     -  
Total assets $ 409,227   $ 352,905  

Liabilities and Shareholders' Equity

Current liabilities:
Accounts payable, accrued expenses and other liabilities $ 28,421 $ 32,502
Contingent payables   3,315     -  
Total current liabilities   31,736     32,502  
Long-term liabilities:
Contingent payables - 2,573
Accrued deferred rent 1,419 1,842
Other liabilities 2,221 2,582
Deferred tax liabilities   7,408     5,768  
Total long-term liabilities   11,048     12,765  
Total liabilities   42,784     45,267  
Shareholders' equity:
Preferred stock - $.01 par value; 5,000,000 shares authorized; none issued - -
Common stock - $.01 par value; 125,000,000 shares authorized;
89,961,818 shares issued and 84,973,280 shares outstanding at September 30, 2011;
88,341,546 shares issued and 83,353,008 shares outstanding at December 31, 2010 900 883
Capital in excess of par value 226,584 204,450
Retained earnings 148,356 111,702
Treasury stock, at cost; 4,988,538 shares at September 30, 2011
and December 31, 2010   (9,397 )   (9,397 )
Total shareholders' equity   366,443     307,638  
Total liabilities and shareholders' equity $ 409,227   $ 352,905  
Consolidated Statements of Cash Flows
For the Nine Months Ended September 30, 2011 and 2010

(in thousands)




Nine months ended September 30,



Operating activities:
Net income $ 36,654 $ 27,737
Adjustments to reconcile net income to net cash provided by
operating activities:
Depreciation and amortization 14,930 11,478
Stock-based compensation expense 5,884 5,334
Deferred income taxes 1,508 546
Decrease in allowance for doubtful accounts (149 ) 464
Change in fair value of contingent consideration 391 -
Loss on disposal of fixed assets 5 22
Changes in assets and liabilities:
(Increase)/Decrease in accounts receivable (10,371 ) (10,020 )
(Increase)/Decrease in prepaid expenses, prepaid income taxes
and other current assets 2,306 (1,138 )
(Increase)/Decrease in other assets 57 685
(Decrease)/Increase in accounts payable, accrued expenses
and other liabilities   (2,125 )   (43 )
Net cash provided by operating activities   49,090     35,065  
Investing activities:
Investment in certificate of deposit (4,809 ) -
Purchases of property and equipment (13,092 ) (10,488 )
Purchase of building and land - (9,886 )
Acquisition of AMG-SIU 161 (12,795 )
Acquisition of Verify Solutions (500 ) -
Acquisition of Chapman Kelly - (13,001 )
Investment in capitalized software   (1,502 )   (1,512 )
Net cash used in investing activities   (19,742 )   (47,682 )
Financing activities:
Proceeds from exercise of stock options 9,013 5,486
Payments of tax withholdings on behalf of employees for (903 ) -
net-share settlement for stock-based compensation
Excess tax benefit from exercised stock options   8,157     8,303  
Net cash provided by financing activities   16,267     13,789  
Net increase in cash and cash equivalents 45,615 1,172
Cash and cash equivalents at beginning of period 94,836 64,863
Cash and cash equivalents at end of period $ 140,451   $ 66,035  
Supplemental disclosure of cash flow information:
Cash paid for income taxes $ 11,547   $ 11,269  
Cash paid for interest $ 89   $ 46  
Supplemental disclosure of noncash investing activities:          
Accrued property and equipment purchases $ 438   $ 674  
Accrued acquisition related contingent consideration $ 351   $ 2,573  


(In thousands, except share and per share amounts)


Reconciliation of net income to EBITDA and adjusted EBITDA

Three Months Ended
September 30,

Nine months Ended
September 30,

  2011       2010     2011       2010  
Net Income $



$ 11,046 $



$ 27,737
Net interest (income)/expense 5 (8 ) 15 (3 )
Income taxes 9,822 7,209 24,691 18,414
Depreciation and amortization, net of deferred
financing costs included in net interest expense   5,125     4,171     14,930     11,478  
Earnings before interest, taxes, depreciation
and amortization (EBITDA) 29,367 22,418 76,290 57,626
Share-based compensation expense   1,918     1,906     5,884     5,334  
Adjusted EBITDA $ 31,285   $ 24,324   $ 82,174   $ 62,960  

Reconciliation of net income to GAAP EPS and
Adjusted EPS

For the Year Ended
December 31,

  2011     2012  
Net Income $ 52,100 $ 65,600
Stock option expense 4,905 5,956
Amortization of intangibles   3,964     3,959  
Subtotal $ 60,969   $ 75,515  
Weighted average common shares, diluted   86,916     88,700  
Diluted GAAP EPS $ 0.60   $ 0.74  
Diluted adjusted EPS $ 0.70   $ 0.85  

HMS Holdings
Investor Relations
Christine Rogers Saenz, 212-857-5986
Media Relations
Francesca Marraro, 212-857-5442

Source: HMS Holdings Corp.

News Provided by Acquire Media